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Summary 
The human cytokine interferon-inducible  protein 10 (IP-10) is a small glycoprotein secreted by 
activated T cells, monocytes, endothelial cells, and keratinocytes, and is structurally related to 
a family of chemotactic cytokines called chemokines.  Although this protein is present in sites 
of delayed-type hypersensitivity reactions and lepromatous leprosy lesions, the biological activity 
of IP-10 remains unknown. We report here that recombinant human IP-10 stimulated significant 
in vitro chemotaxis  of human peripheral blood monocytes but not neutrophils.  Recombinant 
human IP-10 also stimulated chemotaxis of stimulated, but not unstimulated, human peripheral 
blood T lymphocytes. Phenotypic analysis of the stimulated T cell population responsive to IP-10 
demonstrated that stimulated CD4 + and CD29 + T  cells migrated in response to IP-10. This 
resembles the biological activity of the previously described T cell chemoattractant R.ANTES. 
Using an endothelial cell adhesion assay, we demonstrated that stimulated T cells pretreated with 
optimal doses of IP-10 exhibited a greatly enhanced ability to bind to an interleukin 1-treated 
endothelial cell  monolayer.  These results  demonstrate  that  the  IP-10  gene encodes  for  an 
inflammatory mediator that specifically  stimulates the directional migration of T cells and monocytes 
as well as potentiates  T  cell adhesion to endothelium. 
T 
he accumulation of mononuclear cells at sites of antigenic 
challenge appears to be mediated by the local produc- 
tion and secretion of chemotactic cytokines. Several recently 
cloned cytokines constitute a family of chemotactic cytokines 
(chemokines) related by a conserved motif containing four 
cystdne residues (1). IL-8, 3-thromboglobulin  (/3-TG), platelet 
factor 4 (PF-4), GKO, ENA-78, and IFN-inducible protein 
10 (IP-10) are members of the c~ (or c-x-c) chemokine family, 
while macrophage inflammatory protein 1 (MIP-1), RANTES, 
macrophage chemotactic and activating factor (MCAF), and 
1-309 are included in the 3  (or c-c) chemokine part of the 
family. All but one of these cytokines have been found to 
induce the directional migration of various cell types, including 
neutrophils,  monocytes, T lymphocytes, basophils, or fibro- 
blasts, hence the recently proposed nomenclature "chemokines" 
for this cytokine family. Many of the c~ chemokine subfamily 
members, namely IL-8, GRO/melanoma growth-stimulating 
activity (MGSA), neutrophil-attracting peptide 2 (NAP-2), 
a cleavage product of 3-TG, and ENA-78, have been shown 
to chemoattract and activate neutrophils (1, 2). In contrast, 
many of the  ff chemokine subfamily  members,  such  as 
MCAF/macrophage chemotactic protein 1 (MCP-1), MIP- 
lc~ and MIP-13, R.ANTES, and 1-309, chemoattract and ac- 
tivate monocytes  while RANTES and IL-8 also chemoat- 
tract  T  lymphocytes  (3-5).  In addition, we have recently 
demonstrated that MIP-lc~ and MIP-13 are potent T  cell 
chemoattractants (6). 
The human gene for IP-10 was initially identified by its 
expression in IFN-treated monocytes  (7). Although it has 
been several years since the molecular cloning of the IP-10 
gene (8, 9), no biological  function has yet been reported. 
The expression of IP-10 in lepromatous leprosy lesions (10) 
and in delayed-type hypersensitivity responses (11) suggests 
that this chemokine may play an important role in the gener- 
ation of an immune response. To gain insight into the physi- 
ological importance of this chemokine, we have tested purified 
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trophil chemotactic activity. The results demonstrate that rhlP- 
10 is chemotactic for both monocytes and stimulated T cells, 
but unlike many of the other c~ chemokine subfamily members, 
has only weak chemotactic activity for neutrophils. In addi- 
tion, stimulated, but not unstimulated,  CD4 + and CD29 + 
T cells are chemoattracted by rhlP-10. Purified T cells treated 
with rhlP-10 also have an increased capacity to adhere to IL- 
l-treated human umbilical vein endothelial ceils (HUVEC). 
Our results suggest that rhlP-10 may play an important role 
in regulating migration of T lymphocytes and monocytes to- 
wards  sites of antigenic challenge. 
Materials  and  Methods 
Cells.  PBMC were obtained from normal donors by leukaphe- 
resis. The donors had given informed consent. T ceils and T cell 
subsets were purified using previously described techniques (12). 
Briefly,  PBMC  were passaged  over FicoU-Hypaque to  remove 
erythrocytes, granulocytes" and cellular debris. Small lymphocytes 
were obtained by sequential depletion of adherent cells in plastic 
flasks, B lymphocytes on nylon wool columns, and large granuhr 
lymphocytes by Percoll gradient centrifugation. This isolation pro- 
cedure typically yielded >90% CD3§  -  lymphocytes. For T 
cell subset isolation, lymphocyte preparations were washed twice 
in cold PBS and resuspended at 2-3  x  107 ceils/ml. Saturating 
concentrations of anti-CD4,  anti-CDH, anti-CD45ILA, or anti- 
CD45KO were added to the T cell suspension for overnight incu- 
bation at 4~  Purified CD4 +, CD8 +, CD45RA +  , and CD29 + 
lymphocytes were obtained through negative selection using goat 
anti-mouse-specific Fc beads  (Advanced  Magnetics, Cambridge, 
MA) to sdectively deplete the unfractionated T  cell populations 
of  particular T cell subsets as described previously (12). This proce- 
dure routinely yielded a >94% purified T cell subpopulation. For 
antibody activation of T cells or T cell subsets, the T cell prepara- 
tions were adjusted to a concentration of 5  x  106 cells/ml and cul- 
tured on tissue culture plates previously coated with a 10-gg/ml 
suspension of anti-CD3 mAb. The T cells were cultured for 6-8 h, 
harvested,  and used in T  cell chemotaxis assays. 
Chemokines.  Purified rhIP-10 was expressed in Escherichia coli 
and purified by K. Matsushima (Kanazawa University). rhKANTES 
was also expressed in E. coli and was purchased from Pepro Tech 
Inc. (Rocky Hill, NJ). 
ChemotaxisAssay.  Cell migration was evaluated by using a 48- 
well microchemotaxis chamber technique (13) with polycarbonate 
filters (5-gm pore size; Nudeopore Corp., Pleasanton, CA). In the 
monocyte and neutrophil chemotactic assays, cells and chemokines 
were  resuspended  in  R.PMI  1640  containing  1%  BSA  at  106 
cells/ml, and 50/A/well was applied to the upper chamber. N-FMLP 
(Sigma Chemical Co., St. Louis,  MO) at 10-7 M was used as a 
positive control, and all responses and filters were assayed in tripli- 
cate. Migration was allowed to continue at 37~  for 30-60 rain. 
After the nonmigrating ceils were washed from the upper surface 
of the filters, migrating cells were fixed in methanol and stained 
with Diff-Quik, and the numbers of migrating cells in five high- 
powered fields were counted for each well. The results represent 
the  average  number  of migrating  cells per  high-powered field 
(_+  SD). 
T lymphocyte migration was quantitated by a modification of 
the Boyden chamber technique. Briefly, T cells were suspended  at 
107 cells/ml in R.PMI  1640 plus 0.5% FCS,  and were placed in 
the top wells of a 48-well microchemotaxis chamber. The upper 
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and lower wells were separated by a 5-gm pore size polycarbonate 
filter that separated  the cells from the control and experimental 
samples in the bottom wells. All polycarbonate filters used in these 
experiments were coated with collagen type IV 1-2 h before use 
in the assay (6, 14). The chambers were incubated for 4 h at 37~ 
in a 5% CO2 moist atmosphere, and the filters were prepared as 
already outlined. It should be noted that large clumps of T lym- 
phocytes  were  observed  migrating  through  the  filter  making 
enumeration of migrating T cells all,cult. The data are expressed 
as the number of countable cells per high-power field; however, 
this may represent a considerable underestimate of the total number 
of cells that migrated into or through the filter.  The statistical 
significance of  cell migration in response to various concentrations 
of chemokines was determined using a repeated measure one-way 
analysis of variance  (ANOVA).  Results of these calculations are 
listed in the legends of each figure. 
Adhesion Assay.  HUVEC were prepared by collagenase  treat- 
ment of umbilical  cords as previously described (15). Endothelial 
cells at passage three or earlier were plated at 1.5  x  10  s cells/well 
onto gelatin-coated 24-well plates (Costar, Cambridge, MA) and 
cukured to confluence over 48 h. Before the adhesion assays HUVEC 
were washed once with RPMI 1640/5% FCS and then incubated 
in this medium for 6 h at 37~  with or without the addition of 
10 ng/ml of rhIblc~. 
The measurement of T cell adhesion was based upon the binding 
of SlCr-labeled T  cells as previously described (16). Briefly, after 
preincubation, HUVEC were washed twice with medium (RPMI 
1640/5~  FCS) and 500,000 SlCr-labeled T  cells were added to 
each well in a final volume of 500 gl. The plates were incubated 
at 37~  for 60 rain and then washed three times with prewarmed 
medium using a standardized wash procedure. The contents of each 
well were lysed with 300 IA of 1% Triton X-100 and 3, emissions 
counted. Wells were inspected before lysis to ensure that the in- 
tegrity of the HUVEC monolayer had been maintained. Total counts 
added and spontaneously released were determined for each vari- 
able in the assays. 
Percentage adhesion was calculated  according to the following 
formula: percentage adhesion =  100 x  [measured cpm/(total cpm 
-  spontaneously released cpm)]. The statistical significance of these 
results was determined using an unpaired student's t test. 
Results 
Purified rhlP-lO Is Chemotactic for Stimulated  but Not  Un- 
stimulated Human T LTmphocytes.  The results (Fig. 1) dem- 
onstrate that stimulated T lymphocytes consistendy responded 
to concentrations of IP-10 ranging from 1 to 10 ng/ml. Higher 
concentrations (>--25 ng/ml) demonstrated litde or no repro- 
ducible activity on T  cells, thus yielding the typical "bell- 
shaped" chemotaxis dose-response curve, tLANTES induced 
significandy higher T ceil migration at similar concentrations. 
Unstimulated  T  cells ordy exhibited migratory activity to 
R.ANTES but  not  to IP-10. 
The Effect of Human IP-IO on the Chemotactic Response of 
Subsets of Stimulated CD4 +, CD8 +, CD29 +, and CD45RA + 
T Lymphocytes.  Since RANTES has been reported to be a 
sdective chemoattractant for memory CD4 + T  cells (5), the 
effects of rhlP-10 on subsets of T  lymphocytes were inves- 
tigated. The phenotypic characteristics of chemotactic T lym- 
phocytes were determined through the use of negative sdec- 
tion to enrich for T  cell subpopulations.  The results  (Fig. 
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Figure  1.  Human  peripheral 
blood  T  lymphocyte migration in 
response  to  R.ANTES and  IP-10. 
Human lymphocytes were isolated 
from venous blood and either placed 
in culture (unstiraulated) or stimu- 
lated  on  anti-CD3-coated  plates 
(stimulated)  for 6-8 h.  Results de- 
termined as described in Materials 
and Methods  are expressed as the 
mean number of migrating ceils per 
high-power  fidd  (•  of  three 
replicate  experiments.  The  dose- 
response effects of chemokines on 
T  cells  were  determined  to  be 
significant  for  unstimulated  T 
ceils/R_ANTES  (y  <0.04  [F  = 
7.3]), stimulated T cells/R.ANTES 
(/, <0.0002  IF =  9.1]),  and stimu- 
lated  T  cells/IP-10  ~  <0.0025 
[F  =  5.6])  using a repeated mea- 
sure ANOVA. 
2) show significant  migration  of anti-CD3-stimulated  but 
not  unstimulated  CD4 +  T  cells  to  rhlP-10.  However, 
RANTES  induced significantly  more migration  of CD4 + 
T  cells regardless  of the activation  state. 
Further fractionation of T  lymphocytes into naive  (CD- 
45RA +) and memory (CD29 +) T cell subsets revealed that 
both stimulated  CD451LA + and CD29 + cells migrated to 
RANTES,  while only stimulated CD29 + T cells migrated 
significantly in response to IP-10 (Fig. 3). Unstimulated naive 
and memory T  cell populations failed to respond to IP-10, 
but both subsets were chore￿9  by RANTES. RANTES 
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was previously reported to show a preferential  migration of 
memory  CD4 §  CD45RO +,  but  not  naive  CD4 +  CD- 
45RA + or CD8 + T  lymphocytes  (2,  5).  However,  in  our 
hands,  RANTES  chemoattracted  stimulated naive  and memory 
T  cells  (6).  This  discrepancy  may  be  based  on  the  use  of 
collagen-coated chemotaxis falters, which in our experience 
provide a more sensitive reproducible assay of T lymphocyte 
chemotaxis  than the uncoated nitrocellulose filters used by 
Schall et al. (5). These results  suggest that both the activa- 
tion status and phenotypic properties of a T cell population 
determine whether they respond to IP-10 and RANTES. 
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Figaro  2.  rhlP-10  attracts  stimu- 
lated  CD4 +  T  lymphocytes. 
Purified unstimulated T  cells were 
separated by negative selection into 
purified CD4 +  and CD8 + T  cell 
populations  (12),  Results  deter- 
mined as described in Materials and 
Methods are expressed as the mean 
number of migrating cells per high- 
power field (+SE) of five replicate 
experiments.  The  dose-response 
effects  of  chemokines  on  T  cell 
subsets  were  determined  to  be 
significant for unstimulated CD4 + 
T  cells/RANTES (p <0.04  IF  = 
4.3]),  stimulated  CD4 §  T 
cells/R.ANTES  ~  <0.004  IF  = 
9.3]),  stimulated  CD8 +  T 
ceils/R.ANTES  (p  <0.007  l F  = 
19.8]),  and  stimulated  CD4 +  T 
cells/IP-10 (p <0.04 IF =  4.3] using 
a repeated measure ANOVA. 
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Figure  3.  rhlP-10  attracts stimu- 
hted CD29* T lymphocytes.  Using 
similar  purification  protocols  as 
above, highly enriched CD45RA + 
and  CD29 +  T  cell  populations 
were either stimuhted on anfi-CD3- 
coated plates or cultured in medium 
for 6 h. After incubation, the cells 
were  harvested  and  tested  for 
chemotactic  responses to  various 
concentrations of R.ANTES and II)- 
10  as  described  in  Materials  and 
Methods.  Results are expressed as 
the mean number of migrating cells 
per high-power field (_+ SD) of one 
of three representative  experiments. 
The dose-response  effects of chemo- 
kines on T  cell subsets were deter- 
mined to be significant for unstimu- 
fated  CD29 +  T  celIs/RANTES 
(p  <0.004  [F  26.0]),  stimulat- 
ed  CD45RA +  T  cells/RANTES 
(/,  <0.04  [F  =  4.3]),  stimu- 
lated  CD29 +  T  celIs/RANTES 
(p <0.004 IF =  25.4]), and stimulat- 
ed CD29 + T  ceUs/IP-10  (/, <0.004 
IF =  26.0]) using a repeated mea- 
sure ANOVA. 
The Chemotactic  Effect of  Purified rhlP-IO  for Human Neutro- 
phils and Monocytes.  We next examined the effects of IP-10 
on monocyte and neutrophil  migration.  The results shown 
in Fig. 4 demonstrate that both human monocytes and neu- 
trophils migrate in response to lower concentrations  of rhlP- 
10. Monocytes exhibited a modest but significant migration 
to IP-10 at concentrations  of >,-50 ng/ml. Neutrophils also 
demonstrated  significant  migratory  activity  in response  to 
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Figure  4.  Human peripheral blood monocytes but not neutrophils mi- 
grate in response to I1)-10. Human monocytes and neutrophils were iso- 
lated from venous blood and tested for chemotactic  activity using 106 
cells/ml suspended in ILPMI 1640  containing  1%  BSA. Results are ex- 
pressed as the mean number of migrating cells per high-power field (+ SE) 
of three e~periments performed. The dose-response effects were significant 
for both monocytes ~p <0.006  [F  =  6.63]) and neutrophils (p <0.02  [F 
=  9,5])  as determined by repeated  measure ANOVA. 
rhlP-10 at concentrations  of >~50 ng/ml, however, the mag- 
nitude of this response in comparison with monocytes is ex- 
tremely weak and did not exhibit a typical bell-shaped curve. 
Checkerboard analysis of rhlP-10 activity on human mono- 
cytes demonstrated that IP-10-induced migration is chemo- 
tactic rather than chemokinetic (data not shown). 
Effect of rhlP-lO on T Cell Adhesion to IL-I-treated HUVEC. 
Peripheral blood T cells were pretreated with various con- 
centrations ofrhIP-10 and RANTES at 37~  for 6 h on un- 
coated or anti-CD3 antibody-coated plates. After washing, 
lymphocytes were incubated with human umbilical vein en- 
dothdium that has been pretreated with an optimal concen- 
tration of rhIL-lol for the binding assay. The results shown 
in Fig. 5 demonstrate that rhlP-10 and rhRANTES at a con- 
centration of 10 ng/ml were equipotent in augmenting adhe- 
sion of activated but not resting T lymphocytes to IL-l-treated 
endothelium. 
Discussion 
Our findings  that rhlP-10 is chemotactic  for stimulated 
but not unstimulated T lymphocytes are novel. Our data dem- 
onstrate  that  rhlP-10,  like  RANTES,  is also  a monocyte 
chemoattractant. Both chemokines attract monocytes at similar 
dose ranges and possess little activity on neutrophils. Although 
compared with rhRANTES the effect on T cell chemotaxis 
by IP-10 is modest, the more potent effects of rhlP-10 on 
T cell adhesion may reflect the fact that endothelial  cells are 
IP-10 producers and suggest that it may play an important 
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Figure  5.  rhlP-10 induces signi- 
ticant adhesion of stimulated T cells 
to Ibl-treated human umbilical vein 
endothelium.  Lymphocytes were la- 
beled with stCr and preincubated 
on anti-CD3 mAb--coated  or un- 
coated plates with optimal concen- 
trations  of rhlP-10  and R.ANTES 
for 6 h at 37~  Results  are data 
(mean  _+ SD) from a single repre- 
sentative  experiment  of five per- 
formed.  Asterisks  indicate  sig- 
nificant  os  pooled data  points  as 
determined by an unpaired student's 
t test.  * **p <0.005;  *p <0.05. 
role in the entry of T lymphocytes into inflammatory rites 
and sites of  delayed-type  hypersensitivity.  IP-10, like RANTES, 
also appears to selectively recruit and activate specific T cell 
subsets,  rhIP-10  induced significant  migratory activity in 
stimulated CD4 + and CD29 + T lymphocytes, while stimu- 
lated and unstimulated CD4 + as well as stimulated CD8 +, 
CD45RA +,  and CD29 + T  ceils migrated in response to 
rhRANTES. The activity of IP-10 appears to be dependent 
on the activation state of a T cell population and, in contrast 
to RANTES, unstimulated T lymphocytes  were not affected 
by rhlP-10. These results suggest that IP-10 and RANTES 
are not redundant in their actions but play different roles at- 
tracting T  lymphocytes to inflammatory sites. 
T cell adhesion to endothdial cells is necessary for the de- 
velopment of inflammatory and immunological responses. 
Immobilization of T cells on endothelial cells is required for 
recruitment of recirculating T cells from the vascular com- 
partment, followed by transendothelial migration of T cells 
into tissues (17). Cell-cell contact is necessary for specific  im- 
munological recognition by T cells of antigen presented by 
endothelial ceils and other accessory ceils in the context of 
MHC molecules (17-19). Immunological mediators such as 
IFN-3,, TNF-c~, and IL-1 have  been shown to promote these 
functions (17-19). Our findings suggest that the T cell/mono- 
cyte chemoattractants, IP-10 as well as MIP-lc~, MIP-1B, and 
RANTES (6), are all able to augment the T cell component 
of these phenomena, namely adhesion. Purified T cells trig- 
gered through the TCR complex with fixed anti-CD3 mAb 
in the presence of rhlP-10 or rhRANTES resulted in an in- 
creased adhesion to IL-l-treated endothelium when compared 
with control T cell populations. We did not detect alteration 
in surface expression of adhesion molecules on the T cell after 
IP-10 pretreatment. No alteration in the level of surface ex- 
pression of LFA-1, VLA-3, VLA-4, VLA-5, VLA-6, CD44, 
intercellular adhesion molecule 1, vascular cell adhesion mol- 
ecule, and endothelial leukocyte adhesion molecule (ELAM) 
was observed (data not shown). Changes in the conforma- 
tional states of LFA-1 on T cells, Mac-1 on neutrophils,  and 
ELAM-1 on endothelium have been implicated in regulatory 
adhesive phenomena (16-19), and raise the possibility that 
IP-10 may work through this or a similar mechanism.  We 
suggest  that IP-10 may have an important role in vivo in 
promoting endothelial cell-lymphocyte  interactions and sub- 
sequent transmigration of T cells, monocytes, and possibly 
neutrophils in various inflammatory states. Recent data sup- 
porting this hypothesis were communicated  by Dr. Andrew 
Luster (20), demonstrating that mice injected with tumor 
cells transfected with the IP-10 gene exhibited a protective 
antitumor effect  that appeared to require the presence  of  T cells. 
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